In fiscal year 2025, Amgen's revenue by geographical region are as follows:
Learn more about Amgen’s Revenue by Products
Check out competitors to Amgen in a side-by-side comparison.
Explore additional financial metrics for Amgen.
| Non-US | 8384000000 |
|---|---|
| UNITED STATES | 19806000000 |
| Non-US | 9561000000 |
|---|---|
| UNITED STATES | 23863000000 |
| Non-US | 10332000000 |
|---|---|
| UNITED STATES | 26419000000 |
The above chart shows Amgen's revenue percentage share by geographical region.
In fiscal year 2023, Amgen's revenue by region is as follows:
The above chart shows Amgen's revenue percentage share by geographical region.
In fiscal year 2024, Amgen's revenue by region is as follows:
The above chart shows Amgen's revenue percentage share by geographical region.
In fiscal year 2025, Amgen's revenue by region is as follows:
| Geography (Percent Share) | 2023 | 2024 | 2025 |
|---|---|---|---|
| Non-US | 29.74% | 28.61% | 28.11% |
| UNITED STATES | 70.26% | 71.39% | 71.89% |
| Total Revenue | 100% | 100% | 100% |
The above chart shows the revenue trend of different segments of Amgen.
In fiscal year 2025, the UNITED STATES generated the most revenue ($26.42 B), and the Non-US generated the least revenue ($10.33 B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.